COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1369: Articles 13681-13690  | Next

Tear antibodies to SARS-CoV-2: implications for transmission
John Selva, K., Davis, S. K., Haycroft, E. R., Lee, W. S., Lopez, E., Reynaldi, A., Davenport, M. P., Kent, H. E., Juno, J. A., Chung, A. W., Kent, S. J.
10.1101/2021.08.02.21261479 — Posted: 2021-08-04
SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)
Bruminhent, J., Sethaudom, C., Chaumdee, P., Boongird, S., Kiertiburanakul, S., Malathum, K., Nongnuch, A., Phuphuakrat, A., Jirasiritham, S., Janphram, C., Thotsiri, S., Upama, S., Assanatham, M.
10.1101/2021.08.02.21261095 — Posted: 2021-08-04
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Suehiro, M., Okubo, S., Nakajima, K., Kanda, K., Hayakawa, M., Oiso, S., Kabashima, T., Fujita, H., Ando, Y., Muro, T.
10.1101/2021.07.23.21261029 — Posted: 2021-08-04
Aspergillosis and Mucormycosis in COVID-19 Patients; a Systematic Review and Meta-analysis.
Afzal, P. S., Nasir, M.
10.1101/2021.08.01.21261458 — Posted: 2021-08-04
A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination
Mohamed, S. S., Chao, G. Y. C., Isho, B., Zuo, M., Nahass, G. R., Salomon-Shulman, R. E., Blacker, G., Fazel-Zarandi, M., Rathod, B., Colwell, K., Jamal, A., Li, Z., Quinn de Launay, K., Takaoka, A., Fahim, C., Paterson, A., Li, A., Garnham-Takaoka, J., Haq, N., Barati, S., Gilbert, L., Green, K., Mozafarihashjin, M., Samaan, P., Siqueira, W. L., Mubareka, S., Ostrowski, M. A., Rini, J., Rojas, O., McGeer, A., Weissman, I. L., Caspi-Tal, M., Strauss, S., Gingras, A.-C., Gommerman, J.
10.1101/2021.08.01.21261297 — Posted: 2021-08-04 Discussion: Onsite
Association of chronic kidney disease, ethnicity and socioeconomic status with COVID-19 hospitalisation and mortality: a UK Biobank study
Wilkinson, T. J., Lightfoot, C. J., Smith, A. C., Yates, T., Khunti, K., Zaccardi, F.
10.1101/2021.08.02.21261469 — Posted: 2021-08-04
Severity, criticality, and fatality of the SARS-CoV-2 Beta variant
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., AlMukdad, S., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.08.02.21261465 — Posted: 2021-08-04
Airway recommendations for perioperative patients during the COVID-19 pandemic: a scoping review
Grudzinski, A., Sun, B., Zhang, M., Crnic, A., Djokhdem, A. H., Hanna, M., Montroy, J., Duggan, L. V., Hamilton, G. M., Fergusson, D. A., Boet, S., McIsaac, D. I., Lalu, M. M.
10.1101/2021.07.30.21261372 — Posted: 2021-08-04
SARS-CoV-2 B.1.351 (beta) variant shows enhanced infectivity in K18-hACE2 transgenic mice and expanded tropism to wildtype mice compared to B.1 variant
Tarres-Freixas, F., Trinite, B., Pons-Grifols, A., Romero-Durana, M., Riveira-Munoz, E., Avila-Nieto, C., Perez, M., Garcia-Vidal, E., Perez-Zsolt, D., Munoz-Basagoiti, J., Raich-Regue, D., Izquierdo-Useros, N., Blanco, I., Noguera-Julian, M., Guallar, V., Lepore, R., Valencia, A., Vergara-Alert, J., Clotet, B., Ballana, E., Carrillo, J., Segales, J., Blanco, J.
10.1101/2021.08.03.454861 — Posted: 2021-08-03
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
Mothes, W., Li, W., Chen, Y., Prevost, J., Ullah, I., Lu, M., Gong, S. Y., Tauzin, A., Gasser, R., Vezina, D., Anand, S. P., Goyette, G., Chaterjee, D., Ding, S., Tolbert, W. D., Grunst, M. W., Bo, Y., Zhang, S., Richard, J., Zhou, F., Huang, R. K., Esser, L., Zeher, A., Cote, M., Kumar, P., Sodroski, J., Xia, D., Uchil, P. D., Pazgier, M., Finzi, A.
10.1101/2021.08.02.454546 — Posted: 2021-08-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).